15,249 Shares in The Allstate Corporation $ALL Bought by Danske Bank A S

Danske Bank A S bought a new position in shares of The Allstate Corporation (NYSE:ALLFree Report) during the 2nd quarter, according to its most recent disclosure with the SEC. The fund bought 15,249 shares of the insurance provider’s stock, valued at approximately $3,628,000.

Several other institutional investors and hedge funds also recently made changes to their positions in the stock. MV Capital Management Inc. bought a new stake in Allstate in the fourth quarter worth approximately $25,000. Gables Capital Management Inc. bought a new position in shares of Allstate during the 2nd quarter worth approximately $26,000. Navalign LLC acquired a new stake in shares of Allstate during the 4th quarter worth approximately $27,000. Kelleher Financial Advisors acquired a new stake in shares of Allstate during the 2nd quarter worth approximately $28,000. Finally, Evolution Wealth Management Inc. increased its stake in shares of Allstate by 7,000.0% in the 1st quarter. Evolution Wealth Management Inc. now owns 142 shares of the insurance provider’s stock valued at $29,000 after acquiring an additional 140 shares in the last quarter. Institutional investors and hedge funds own 76.47% of the company’s stock.

Key Allstate News

Here are the key news stories impacting Allstate this week:

  • Positive Sentiment: Zacks Research raised several Allstate EPS forecasts, including estimates for Q3 2026, FY2027, FY2028, Q1 2027, Q4 2027 and Q2 2028. Zacks maintains a “Strong-Buy” rating, supporting the view that underwriting performance and earnings power may remain resilient. Allstate earnings estimates
  • Positive Sentiment: A Zacks screen identified ALL as a high-return-on-equity, cash-rich stock that could appeal to investors seeking quality and financial strength during volatile markets. High-ROE stocks article
  • Neutral Sentiment: Allstate opened a new Dallas auto laboratory to train claims adjusters on increasingly complex vehicle technology. The initiative could improve claims accuracy and customer service over time, but it is unlikely to materially affect near-term earnings. Allstate Dallas auto lab
  • Negative Sentiment: Keefe, Bruyette & Woods downgraded ALL from “hold” to “moderate sell,” adding to investor caution around the stock’s valuation and outlook. Allstate analyst downgrade
  • Negative Sentiment: Allstate estimated July catastrophe losses of $682 million pretax, or $539 million after tax. The losses bring pretax catastrophe costs for the current aggregate year to approximately $2.402 billion, creating pressure on underwriting margins and near-term earnings. Allstate July 2026 monthly release
  • Negative Sentiment: Zacks Research lowered its Q2 2027 and Q4 2026 EPS estimates, indicating that analysts still see some periods of earnings pressure despite upward revisions elsewhere. Allstate earnings estimates

Insider Activity

In other news, Director Andrea Redmond sold 2,225 shares of the company’s stock in a transaction dated Monday, June 1st. The stock was sold at an average price of $202.91, for a total value of $451,474.75. Following the completion of the transaction, the director owned 2,225 shares of the company’s stock, valued at $451,474.75. This represents a 50.00% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, COO Mario Rizzo sold 56,225 shares of the stock in a transaction dated Tuesday, August 11th. The stock was sold at an average price of $264.48, for a total value of $14,870,388.00. Following the sale, the chief operating officer owned 82,227 shares of the company’s stock, valued at $21,747,396.96. This represents a 40.61% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold 91,446 shares of company stock worth $24,208,675 over the last ninety days. Corporate insiders own 1.55% of the company’s stock.

Allstate Stock Down 0.3%

Allstate stock opened at $253.82 on Friday. The company has a debt-to-equity ratio of 0.24, a quick ratio of 0.36 and a current ratio of 0.36. The stock has a market cap of $64.18 billion, a PE ratio of 5.07, a price-to-earnings-growth ratio of 0.39 and a beta of 0.16. The stock has a fifty day moving average of $250.34 and a 200 day moving average of $224.95. The Allstate Corporation has a one year low of $188.08 and a one year high of $277.22.

Allstate (NYSE:ALLGet Free Report) last released its earnings results on Wednesday, August 5th. The insurance provider reported $8.99 EPS for the quarter, topping analysts’ consensus estimates of $6.06 by $2.93. The company had revenue of $18.60 billion for the quarter, compared to analysts’ expectations of $15.46 billion. Allstate had a net margin of 18.97% and a return on equity of 41.64%. The firm’s revenue was up 11.8% compared to the same quarter last year. During the same quarter last year, the business earned $5.94 EPS. As a group, sell-side analysts predict that The Allstate Corporation will post 34.45 EPS for the current year.

Allstate Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, October 1st. Shareholders of record on Monday, August 31st will be issued a dividend of $1.08 per share. The ex-dividend date of this dividend is Monday, August 31st. This represents a $4.32 dividend on an annualized basis and a yield of 1.7%. Allstate’s dividend payout ratio (DPR) is currently 8.63%.

Wall Street Analyst Weigh In

ALL has been the subject of a number of research reports. Evercore set a $240.00 price target on shares of Allstate in a report on Friday, July 10th. UBS Group increased their price target on Allstate from $261.00 to $275.00 and gave the stock a “neutral” rating in a report on Monday, August 10th. Wall Street Zen raised Allstate from a “hold” rating to a “buy” rating in a report on Monday, July 20th. Cantor Fitzgerald raised their price objective on Allstate from $236.00 to $242.00 and gave the company a “neutral” rating in a research note on Thursday, July 9th. Finally, Zacks Research raised shares of Allstate from a “hold” rating to a “strong-buy” rating in a report on Monday, August 17th. Four research analysts have rated the stock with a Strong Buy rating, five have issued a Buy rating, eight have given a Hold rating and four have given a Sell rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $265.26.

Read Our Latest Stock Analysis on Allstate

Allstate Profile

(Free Report)

Allstate Corporation is a publicly traded insurance company headquartered in Northbrook, Illinois, and is one of the largest personal lines property and casualty insurers in the United States. Founded in 1931 as a subsidiary of Sears, Roebuck and Co, Allstate has grown into a diversified insurer that serves millions of consumers and businesses through a mix of distribution channels and product offerings.

The company underwrites a broad range of insurance products, with primary emphasis on auto and homeowners coverage.

Featured Articles

Want to see what other hedge funds are holding ALL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Allstate Corporation (NYSE:ALLFree Report).

Institutional Ownership by Quarter for Allstate (NYSE:ALL)

Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.